Harrow to Present at William Blair’s 46th Annual Growth Stock Conference
Harrow (Nasdaq:HROW) announced that management will present at William Blair’s 46th Annual Growth Stock Conference on Wednesday, June 3, 2026, at 8:40 AM CT, in Chicago, IL.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Harrow (Nasdaq:HROW) announced that management will present at William Blair’s 46th Annual Growth Stock Conference on Wednesday, June 3, 2026, at 8:40 AM CT, in Chicago, IL.
The presentation will be webcast live on Harrow’s website, with a replay available for about 90 days.
Details
News Market Reaction – HROW
On May 27, the day this news came out, HROW closed 0.76% above the previous close.
Data tracked by StockTitan Argus for the May 27 session.
Key Figures
- Conference edition
- 46th annual
- William Blair Growth Stock Conference
- Presentation date
- June 3, 2026
- Conference presentation in Chicago
- Presentation time
- 8:40 AM CT
- Scheduled conference session
- Replay availability
- 90 days
- Webcast replay period on company website
Historical Context
-
Q1 revenue with VEVYE adjustment and net loss prompted a sharp selloff.
-
Announcement of Q1 2026 earnings release and webcast schedule.
-
Permanent J-code for IOPIDINE enabling in-office reimbursement from July 1, 2026.
-
Selection of LogiCare3PL as U.S. distribution partner for ophthalmic products.
-
$50.0M senior unsecured notes due 2030 to support corporate initiatives.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NASHVILLE, Tenn., May 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will present at William Blair’s 46th Annual Growth Stock Conference on Wednesday, June 3, 2026, at 8:40 AM CT, in Chicago, IL.
The presentation will be webcast live and can be found on the Company’s website. A replay will be on the website for approximately 90 days following the event.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visit harrow.com and connect with us on LinkedIn.
Contact:
Mike Biega, Vice President of Investor Relations and Communications
mbiega@harrowinc.com
617-913-8890
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.